| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 3 | |
| #3 | United States | 2 | |
| #4 | France | 1 | |
| #5 | Republic of Korea | 1 | |
| #6 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Cacace Janice | 4 |
| #2 | Jayan Arvind | 4 |
| #3 | Hood John | 4 |
| #4 | Soll Richard M | 3 |
| #5 | Noronha Glenn | 3 |
| #6 | Mak Chi Ching | 3 |
| #7 | Pathak Ved | 3 |
| #8 | Renick Joel | 3 |
| #9 | Zeng Binqi | 3 |
| #10 | Mc Pherson Andrew | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020167845A1 | Crystalline forms of a jak2 inhibitor | |
| WO2020068754A1 | Methods of treating myeloproliferative disorders | |
| WO2020068755A1 | Methods of treating myeloproliferative disorders | |
| FR3092581A1 | CRYSTALLINE FORMS OF A JAK2 INHIBITOR | |
| AU2012230091A1 | Bi-aryl meta-pyrimidine inhibitors of kinases |